Market Research Reports

Implantable Drug Delivery Devices (Contraceptives, Drug Infusion Pumps, Intraocular Implants, Drug Eluting, Bio-Absorbable Stents, Biodegradable) Market - Global Industry Analysis, Size, Share, Trends And Forecast 2012 - 2018

104pages
Published Date: 2013-03-04
 

Description



The global implantable drug delivery devices hold a competitive edge over other drugs and devices owing to the fact that they are implanted at targeted sites and so deliver unaltered amounts of drugs to the affected area. These implantable drug delivery devices are categorized into six product types and this report estimates their market in terms of USD million, for the period 2012 – 2018, keeping 2011 as the base year.

The market is segmented on the basis of product types into implantable infusion pumps, brachytherapy seeds, contraceptive implants, drug eluting stents, bio-absorbable stents and intraocular drug delivery implants. The market for all these product segments is provided in this report for four major geographic regions namely North America, Europe, Asia and the rest of the world regions (RoW). The market is segmented on the basis of technology into biodegradable and non-biodegradable implant technology and on the basis of applications into oncology, cardiovascular, contraceptive, ophthalmology and others (diabetes, inflammatory conditions). 

A competitive landscape, mapping all the market players and their respective market shares for 2011 are provided in this report along with some major business strategies adopted by these players to accentuate market shares. A chapter on recommendations for existing and new entrants is also provided.

Some of the major players profiled in this report are Allergan Inc, Bayer HealthCare, Medtronic Inc., Nucletron, Merck, pSivida Corp., Boston Scientific Corporation, Abbott Laboratories and Bausch and Lomb Inc. All these market players are profiled in this report via parameters such as company overview, financial overview, business strategies, product portfolio and recent developments. 

The global implantable drug delivery devices market is segmented into the following categories:

Implantable Drug Delivery Devices Market by Product Types
  • Implantable coronary drug eluting stents
  • Implantable bio-absorbable stents
  • Implantable contraceptive drug delivery devices
  • Implantable intraocular drug delivery devices
  • Implantable brachytherapy seeds
  • Implantable drug infusion pumps
Implantable Drug Delivery Devices Market by Technology
  • Biodegradable implantable drug delivery device technology
  • Non-biodegradable implantable drug delivery device technology
Implantable Drug Delivery Devices Market by Applications
  • Ophthalmology
  • Cardiovascular
  • Birth control/contraception
  • Oncology
  • Other (diabetes, chronic pain causing diseases)
Implantable Drug Delivery Devices Market by Geography
  • North America
  • Europe
  • Asia
  • Rest of the world (RoW)

Table of Contents



Chapter 1 Preface
1.1 Report Description
1.2 Research Methodology
1.3 Market Segmentation: Implantable Drug Delivery Devices Market

Chapter 2 Executive Summary

Chapter 3 Market Overview
3.1 Market Dynamics
      3.1.1 Market Drivers
               3.1.1.1 Market Drivers For The Global Coronary Stents (Drug-Eluting And Bio-Absorbable Stents) Market
                          3.1.1.1.1 Increasing Prevalence Of Cardiovascular Diseases
                          3.1.1.1.2 Rising Number Of Interventional Cardiologists
                          3.1.1.1.3 Increasing Demand For Minimally Invasive Procedures
               3.1.1.2 Impact Analysis Of The Market Drivers For The Global Coronary Stents (Drug-Eluting And Bio-Absorbable Stents) Market
               3.1.1.3 Market Drivers For The Global Brachytherapy Seeds Market
                          3.1.1.3.1 Increasing Global Prevalence Of Prostate Cancer
                          3.1.1.3.2 Emergence Of New Disease Applications (Cervical Cancer, Breast Cancer)
               3.1.1.4 Impact Analysis Of Market Drivers For The Global Brachytherapy Seeds Market
               3.1.1.5 Market Drivers For The Global Implantable Drug Infusion Pumps Market
                          3.1.1.5.1 Rising Prevalence Of Global Colorectal Cancer
                          3.1.1.5.2 High Prevalence Of Chronic Pain-Causing Disorders
               3.1.1.6 Impact Analysis Of Market Drivers For The Global Implantable Drug Infusion Pumps Market
               3.1.1.7 Market Drivers For The Global Intraocular Drug Delivery Implants Market
                          3.1.1.7.1 Global Aging Population
                          3.1.1.7.2 Rising Patient Pool For Diabetes And Diabetic Retinopathy
               3.1.1.8 Impact Analysis Of Market Drivers For The Global Intraocular Drug Delivery Implants Market
               3.1.1.9 Market Drivers For The Global Contraceptive Drug Delivery Implants Market
                          3.1.1.9.1 Growing Prevalence Of Unwanted Pregnancies
                          3.1.1.9.2 Government And NGO Initiatives To Promote Contraceptive Products
               3.1.1.10 Impact Analysis Of Market Drivers For The Global Contraceptive Drug Delivery Implants Market
      3.1.2 Market Restraints
               3.1.2.1 Product Recalls, Lawsuits And The Introduction Of Internal Product Substitutes
               3.1.2.2 Stringent FDA And CE Approval Norms
               3.1.2.3 Implementation Of The Affordable Healthcare For America Act, 2010
               3.1.2.4 Impact Analysis Of The Market Restraints
      3.1.3 Opportunities
               3.1.3.1 Introduction Of New And Advanced Implantable Drug Delivery Devices
                          3.1.3.1.1 Microchips
                          3.1.3.1.2 Introduction Of Biodegradable Technology Based Products
3.2 Market Attractiveness Analysis For The Global Implantable Drug Delivery Devices Market
      3.2.1 Market Attractiveness Analysis Of The Global Implantable Drug Delivery Devices Market By Product Types
      3.2.2 Market Attractiveness Analysis Of The Global Implantable Drug Delivery Devices Market By Geography
3.3 Market Scenario And Market Trends
      3.3.1 Global Implantable Drug Devices Market, 2011 – 2018 (USD Million)

Chapter 4 Implantable Drug Delivery Devices Market, By Product Types
4.1 Overview
4.2 Global Implantable Coronary Drug Eluting Stents Market
      4.2.1 Global Implantable Coronary Drug Eluting Stents Market, 2010 – 2018 (USD Million)
4.3 Global Implantable Bio-Absorbable Stents Market
      4.3.1 Global Implantable Bio-Absorbable Stents Market, 2014 – 2018 (USD Million)
      4.3.2 Implantable Bio-Absorbable Stents - Manufacturers And Product Availability Status
4.4 Global Implantable Brachytherapy Seeds Market
      4.4.1 Global Implantable Brachytherapy Seeds Market, 2010 – 2018 (USD Million)
      4.4.2 Global Implantable Brachytherapy Seeds Market By Product Types, 2010 – 2018 (USD Million)
4.5 Global Implantable Drug Infusion Pumps Market
      4.5.1 Global Implantable Drug Infusion Pumps Market, 2010 – 2018 (USD Million)
4.6 Global Intraocular Drug Delivery Implants Market
      4.6.1 Global Intraocular Drug Delivery Implants Market, 2010 – 2018 (USD Million)
4.7 Global Contraceptive Drug Delivery Implants Market
      4.7.1 Intravaginal Rings
      4.7.2 Hormonal IUDs
      4.7.3 Subdermal Contraceptive Implants
      4.7.4 Global Contraceptive Drug Delivery Implants Market, 2010 – 2018 (USD Million)
      4.7.5 Global Contraceptive Implants Market By Product Types, 2010 – 2018 (USD Million)

Chapter 5 Global Implantable Drug Delivery Devices Market, By Technology
5.1 Overview
5.2 Global Biodegradable Drug Delivery Implant Technology Market
      5.2.1 Global Biodegradable Drug Delivery Implant Technology Market, 2010 – 2018 (USD Million)
5.3 Global Non – Biodegradable Drug Delivery Implant Technology Market
      5.3.1 Global Non – Biodegradable Drug Delivery Implant Technology Market, 2010 – 2018 (USD Million)

Chapter 6 Global Implantable Drug Delivery Devices Market, By Applications
6.1 Overview
6.2 Global Implantable Drug Delivery Devices For Ophthalmology Market
      6.2.1 Global Implantable Drug Delivery Devices In Ophthalmology Market, 2010 – 2018 (USD Million)
6.3 Global Implantable Drug Delivery Devices For Birth Control/Contraceptive Market
      6.3.1 Global Implantable Drug Delivery Devices For Birth Control/Contraceptive Market, 2010 – 2018 (USD Million)
6.4 Global Implantable Drug Delivery Devices For Cardiovascular Market
      6.4.1 Global Implantable Drug Delivery Devices For Cardiovascular Market, 2010 – 2018 (USD Million)
6.5 Global Implantable Drug Delivery Devices For Oncology Market
      6.5.1 Global Implantable Drug Delivery Devices For Oncology Market, 2010 – 2018 (USD Million)
6.6 Global Implantable Drug Delivery Devices For Others Market
      6.6.1 Global Implantable Drug Delivery Devices For Others Market, 2010 – 2018 (USD Million)

Chapter 7 Implantable Drug Delivery Devices Market By Geography
7.1 Overview
7.2 North America
      7.2.1 North America Implantable Drug Delivery Devices Market, 2010 – 2018 (USD Million)
      7.2.2 Comparative Analysis Of The North American Implantable Drug Delivery Devices Market By Product Types, 2011 & 2018 (%)
      7.2.3 The North American Implantable Drug Delivery Devices Market, By Product Types, 2010 – 2018 (USD Million)
7.3 Europe
      7.3.1 Europe Implantable Drug Delivery Devices Market, 2010 – 2018 (USD Million)
      7.3.2 Comparative Analysis Of The European Implantable Drug Delivery Devices Market By Product Types, 2011 & 2018 (%)
      7.3.3 Europe Implantable Drug Delivery Devices Market, By Product Types, 2010 – 2018 (USD Million)
7.4 Asia
      7.4.1 Asia Implantable Drug Delivery Devices Market, 2010 – 2018 (USD Million)
      7.4.2 Comparative Analysis Of The Asian Implantable Drug Delivery Devices By Product Types, 2011 & 2018 (%)
      7.4.3 Asia Implantable Drug Delivery Devices Market, By Product Types, 2010 – 2018 (USD Million)
7.5 Rest Of The World (RoW)
      7.5.1 RoW Implantable Drug Delivery Devices Market, 2010 – 2018 (USD Million)
      7.5.2 Comparative Analysis Of The RoW Implantable Drug Delivery Devices By Product Types, 2011 & 2018 (%)
      7.5.3 RoW Implantable Drug Delivery Devices Market, By Product Types, 2010 – 2018 
(USD Million)

Chapter 8 Recommendations
8.1 Investing In Emerging Technologies And Identifying New Target Disease Segments To Invent New Products Catering To Nascent Segments, E.G. Microchips
8.2 Conducting Clinical Trials Via External Funding
8.3 Investing In Emerging Economies
8.4 Conducting Rigorous Research And Development Exercises
8.5 Investing In Advertising Campaigns
8.6 Tracking Patent Expiration Of Branded Products

Chapter 9 Competitive Landscape
9.1 Market Share Analysis, By Product Types, 2011
      9.1.1 Market Share Analysis For The Global Coronary Drug Eluting Stents Market, By Key Players, 2011
      9.1.2 Market Share Analysis For The Global Brachytherapy Seeds Market, By Key Players, 2011
      9.1.3 Market Share Analysis For The Global Intraocular Drug Delivery Implants Market, 2011
      9.1.4 Market Share Analysis For The Global Contraceptive Drug Delivery Implants Market, 2011

Chapter 10 Company Profiles
10.1 Merck
      10.1.1 Company Overview
      10.1.2 Financial Overview
      10.1.3 Business Strategies
                10.1.3.1 Corporate Social Responsibility
                10.1.3.2 R&D Initiatives
                10.1.3.3 Advertising And Internet Marketing
      10.1.4 Product Portfolio
      10.1.5 Recent Developments
10.2 Bausch & Lomb Inc.
      10.2.1 Company Overview
      10.2.2 Financial Overview
      10.2.3 Business Strategies
                10.2.3.1 Mergers, Acquisitions, And Takeovers
      10.2.4 Product Portfolio
      10.2.5 Recent Developments
10.3 Medtronic Inc.
      10.3.1 Company Overview
      10.3.2 Financial Overview
      10.3.3 Business Strategies
                          10.3.3.1.1 Investments In R&D
                          10.3.3.1.2 Investing In Emerging Economies
                          10.3.3.1.3 Patent Filing
                          10.3.3.1.4 Mergers And Acquisitions
      10.3.4 Product Portfolio
      10.3.5 Recent Developments
10.4 Allergan, Inc.
      10.4.1 Company Overview
      10.4.2 Financial Overview
      10.4.3 Business Strategies
                10.4.3.1 Investing In  Research And Development
                10.4.3.2 Providing Innovative Products
      10.4.4 Product Portfolio
      10.4.5 Recent Developments
10.5 Psivida Corp.
      10.5.1 Company Overview
      10.5.2 Financial Overview
      10.5.3 Business Strategies
                10.5.3.1 Filing Patents
                10.5.3.2 Strategic Alliance Development
      10.5.4 Product Portfolio
      10.5.5 Recent Developments
10.6 Bayer Healthcare
      10.6.1 Company Overview
      10.6.2 Financial Overview
      10.6.3 Business Strategies
                          10.6.3.1 R&D Initiatives
                          10.6.3.2 Investment In Growing Economies
                          10.6.3.3 Advertising Campaigns
      10.6.4 Product Portfolio
      10.6.5 Recent Developments
10.7 Nucletron
      10.7.1 Company Overview
      10.7.2 Financial Overview
      10.7.3 Business Strategies
                10.7.3.1 Training And Development
      10.7.4 Product Portfolio
      10.7.5 Recent Developments
10.8 Boston Scientific Corporation
      10.8.1 Company Overview
      10.8.2 Financial Overview
      10.8.3 Business Strategies
                10.8.3.1 Market Expansion By Entering Into Emerging Economies Like India, China And Brazil
                10.8.3.2 Cost Controlling And Quality Enhancement Through R&D Restructuring
                10.8.3.3 Mergers And Acquisitions
                10.8.3.4 Innovation
      10.8.4 Product Portfolio
      10.8.5 Recent Developments
10.9 Abbott Laboratories
      10.9.1 Company Overview
      10.9.2 Financial Overview
      10.9.3 Business Strategies
                10.9.3.1 Business Diversification
                10.9.3.2 R&D Initiatives
                10.9.3.3 Investing In Emerging Markets
      10.9.4 Product Portfolio
      10.9.5 Recent Developments

LIST OF FIGURES

Fig. 1 Market Segmentation: Implantable Drug Delivery Devices Market
Fig. 2 Global Implantable Drug Delivery Devices Market By Product Types, 2018 (USD Million)
Fig. 3 Market Attractiveness Analysis Of The Global Implantable Drug Delivery Devices Market By Product Types
Fig. 4 Market Attractiveness Analysis Of The Global Implantable Drug Delivery Devices Market By Geography
Fig. 5 Global Implantable Drug Delivery Devices Market, 2010 – 2018 (USD Million)
Fig. 6 Comparative Analysis Of The Global Implantable Drug Delivery Devices Market By Product Types, 2011 & 2018 (%)
Fig. 7 Global Implantable Coronary Drug Eluting Stents Market, 2010 – 2018 (USD Million)
Fig. 8 Global Implantable Bio-Absorbable Stents Market, 2014 – 2018 (USD Million)
Fig. 9 Global Implantable Brachytherapy Seeds Market, 2010 – 2018 (USD Million)
Fig. 10 Global Implantable Drug Infusion Pumps Market, 2010 – 2018 (USD Million)
Fig. 11 Global Intraocular Drug Delivery Implants Market, 2010 – 2018 (USD Million)
Fig. 12 Global Contraceptive Drug Delivery Implants Market, 2010 – 2018 (USD Million)
Fig. 13 Comparative Analysis Of The Global Implantable Drug Delivery Devices Market By Technology Types, 2011 & 2018 (%)
Fig. 14 Global Biodegradable Drug Delivery Implant Technology Market, 2010 – 2018 (USD Million)
Fig. 15 Global Non – Biodegradable Drug Delivery Implant Technology Market, 2010 – 2018 (USD Million)
Fig. 16 Comparative Analysis Of Global Implantable Drug Delivery Devices By Application, 2011 & 2018 (%)
Fig. 17 Global Implantable Drug Delivery Devices In Ophthalmology Market, 2010 – 2018 (USD Million)
Fig. 18 Global Implantable Drug Delivery Devices For Birth Control/Contraceptive Market, 2010 – 2018 (USD Million)
Fig. 19 Global Implantable Drug Delivery Devices For Cardiovascular Market, 2010 – 2018 (USD Million)
Fig. 20 Global Implantable Drug Delivery Devices For Oncology Market, 2010 – 2018 (USD Million)
Fig. 21 Global Implantable Drug Delivery Devices For Others Market, 2010 – 2018 (USD Million)
Fig. 22 Comparative Analysis Of The Global Implantable Drug Delivery Devices By Geography, 2011 & 2018 (%)
Fig. 23 North America Implantable Drug Delivery Devices Market, 2010 – 2018 (USD Million)
Fig. 24 Comparative Analysis Of The North American Implantable Drug Delivery Devices By Product Types, 2011 & 2018 (%)
Fig. 25 Europe Implantable Drug Delivery Devices Market, 2010 – 2018 (USD Million)
Fig. 26 Comparative Analysis Of European Implantable Drug Delivery Devices By Product Types, 2011 & 2018 (%)
Fig. 27 Asia Implantable Drug Delivery Devices Market, 2010 – 2018 (USD Million)
Fig. 28 Comparative Analysis Of The Asian Implantable Drug Delivery Devices By Product Types, 2011 & 2018 (%)
Fig. 29 RoW Implantable Drug Delivery Devices Market, 2010 – 2018 (USD Million)
Fig. 30 Comparative Analysis Of The RoW Implantable Drug Delivery Devices By Product Types, 2011 & 2018 (%)
Fig. 31 Market Share Analysis For The Global Coronary Drug Eluting Stents Market, By Key Players, 2011
Fig. 32 Market Share Analysis For The Global Brachytherapy Seeds Market, By Key Players, 2011
Fig. 33 Merck: Annual Revenues, 2009 – 2011 (USD Million) (Conversion Rate: 1 Euro = 1.34 USD)
Fig. 34 Medtronic Inc.: Net Sales, 2009 – 2011 (USD Million)
Fig. 35 Allergan Inc.: Annual Revenues, 2009 – 2011 (USD Million)
Fig. 36 Psivida: Annual Revenues, 2009-2011 (USD Million)
Fig. 37 Bayer Healthcare: Annual Revenues, 2009-2011 (USD Million) (Conversion Rate:  1 Euro = 1.34 USD)
Fig. 38 Elekta: Annual Revenues, 2010 - 2011 (USD Million) (Conversion Rate: 1 Sek = 0.16 USD)
Fig. 39 Boston Scientific Corporation: Annual Revenues, 2009-2011 (USD Million)
Fig. 40 Abbott Laboratories: Annual Revenues, 2009-2011 (USD Million)

LIST OF TABLES

Table 1 Market Snapshot: Global Implantable Drug Delivery Devices
Table 2 Impact Analysis Of Market Drivers For The Global Coronary Stents (Drug-Eluting And Bio-Absorbable Stents) Market
Table 3 Impact Analysis Of Market Drivers For The Global Brachytherapy Seeds Market
Table 4 Impact Analysis Of Market Drivers For The Global Implantable Drug Infusion Pumps Market
Table 5 Impact Analysis Of Market Drivers For The Global Intraocular Drug Delivery Implants Market
Table 6 Impact Analysis Of Market Drivers For The Global Contraceptive Drug Delivery Implants Market
Table 7 Impact Analysis Of Market Restraints For The Implantable Drug Delivery Devices Market
Table 8 Key Implantable Drug Eluting Stent Products By Manufacturers
Table 9 Implantable Bio-Absorbable Stents By Manufacturers And Product Availability Status
Table 10 Global Implantable Brachytherapy Seeds Market By Product Types, 2010 – 2018 (USD Million)
Table 11 Global Contraceptive Implants Market By Product Types, 2010 – 2018 (USD Million)
Table 12 The North American Implantable Drug Delivery Devices Market, By Product Types, 2010 – 2018 (USD Million)
Table 13 Europe Implantable Drug Delivery Devices Market, By Product Types, 2010 – 2018 (USD Million)
Table 14 Asia Implantable Drug Delivery Devices Market, By Product Types, 2010 – 2018 (USD Million)
Table 15 RoW Implantable Drug Delivery Devices Market, By Product Types, 2010 – 2018 (USD Million)

Enquiry Before Buying


Free Market Analysis



Implantable drug delivery devices are drug eluting devices implanted at targeted sites for therapeutic applications. The global implantable drug delivery devices market was valued at USD 11.6 billion in 2011 and is expected to grow at a CAGR of 8.8% from 2012 to 2018 to reach an estimated value of USD 21.1 billion in 2018. The Asian implantable drug delivery devices market held a market share of over 15% in 2011 and will register the fastest CAGR during 2012 to 2018 owing to economic development in emerging economies such as India and China. 

In terms of market leaders for individual product segments, Medtronic led the market in the global implantable infusion pumps market in 2011; however, its market share is expected to plummet by 2018 due to the Class I product recall of SynchroMed II in 2012. On the other hand, Boston Scientific Corporation dominated the coronary drug eluting stents market in 2011. Furthermore, Allergan Inc. will dominate the global intraocular drug delivery market in the coming years, owing to the growing popularity of its biodegradable implant – “Ozurdex.” 

Implantable drug delivery devices gain precedence over other drug delivery devices due to the fact that these devices are implanted at the targeted site and deliver unaltered concentrations of drugs at regular intervals. The market overview and trends for the global implantable drug delivery devices is analyzed based on the following attributes:

  • Technological trends: The introduction of biodegradable technology based products such as biodegradable intraocular implants and bio-absorbable stents will accelerate the growth of the overall implantable drug delivery devices market. Moreover, these biodegradable implantable drug delivery devices will act as internal substitutes for already existing products such as non-biodegradable intraocular drug delivery implants and coronary drug eluting stents. 
  • External substitutes: The presence of external substitutes and their technological advancement will restrain the growth of the market. For instance, the market growth of the brachytherapy seeds market is impeded by the advent of new technologies and the improvement of pre-existing alternative technologies such as HDR devices, image guided brachytherapy (IGBT) and pulse dose rate (PDR) treatments. 
  • Barriers to new entrants: Implantable drug delivery devices are categorized as Class I high risk medical devices. The approval process of these medical devices involves complicated and stringent FDA and CE regulations and therefore, is an expensive and lengthy affair. Non-compliance of these regulations leads to product recalls. Moreover, the presence of manufacturers with large revenue base such as Merck, Bayer, and Johnson and Johnson, elevates the barrier to new entrants and makes it very difficult for new entrants to sustain themselves. 
  • Patent expiration: Patent expiration of implantable drug delivery devices plays a very important role in determining the competitive scenario and overall market growth. For instance, the patent for Bayer’s Mirena will expire in 2015 and this will open up the market for generic product manufacturers like Teva Pharmaceuticals.
  • Introduction of cheaper products especially in the global contraceptive drug delivery implants market will drive the market in the future. Manufacturers like Bayer and Merck have entered into strategic agreements with the UN, DFID and Marie Stopes International and are marketing their products in emerging and underdeveloped economies by reducing their prices by approximately 50%. Furthermore, the future market expansion strategies adopted by Shanghai Dahua Pharmaceuticals Co. Ltd., that markets its contraceptive drug delivery implant known as Sino-implant at approximately USD 8, will affect the market by stiffening the competition for players like Merck and Bayer.
europe-implantable-drug-delivery-devices-market-by-product-types-2010-2018
 

To get discount on this report, just click on the button below.

To receive brochure, please click on the button below.

Share This Market Study!  

Upcoming Report

Payment
Copyright @ Transparency Market Research